Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Avirulent anthrax vaccine.

Literature DB >> 20990776

Avirulent anthrax vaccine.

M STERNE.

Abstract

Entities: Species

Keywords: ANTHRAX/vaccine

Mesh：

Substances：
Anthrax Vaccines
Vaccines

Year: 1946 PMID： 20990776

Source DB: PubMed Journal: Onderstepoort J Vet Sci Anim Ind ISSN： 0369-7428

Keyword Cloud
Cited

× No keyword cloud information.

41 in total

1. Bacillus anthracis sortase A (SrtA) anchors LPXTG motif-containing surface proteins to the cell wall envelope.

Authors: Andrew H Gaspar; Luciano A Marraffini; Elizabeth M Glass; Kristin L Debord; Hung Ton-That; Olaf Schneewind
Journal: J Bacteriol Date: 2005-07 Impact factor: 3.490

2. Antibacterial photosensitization through activation of coproporphyrinogen oxidase.

Authors: Matthew C Surdel; Dennis J Horvath; Lisa J Lojek; Audra R Fullen; Jocelyn Simpson; Brendan F Dutter; Kenneth J Salleng; Jeremy B Ford; J Logan Jenkins; Raju Nagarajan; Pedro L Teixeira; Matthew Albertolle; Ivelin S Georgiev; E Duco Jansen; Gary A Sulikowski; D Borden Lacy; Harry A Dailey; Eric P Skaar
Journal: Proc Natl Acad Sci U S A Date: 2017-07-24 Impact factor: 11.205

3. Surface protein IsdC and Sortase B are required for heme-iron scavenging of Bacillus anthracis.

Authors: Anthony W Maresso; Travis J Chapa; Olaf Schneewind
Journal: J Bacteriol Date: 2006-09-29 Impact factor: 3.490

Review 4. The Bacillus cereus Group: Bacillus Species with Pathogenic Potential.

Authors: Monika Ehling-Schulz; Didier Lereclus; Theresa M Koehler
Journal: Microbiol Spectr Date: 2019-05

Review 5. New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.

Authors: J M Beierlein; A C Anderson
Journal: Curr Med Chem Date: 2011 Impact factor: 4.530

6. The Bacillus anthracis protein MprF is required for synthesis of lysylphosphatidylglycerols and for resistance to cationic antimicrobial peptides.

Authors: Shalaka Samant; Fong-Fu Hsu; Alexander A Neyfakh; Hyunwoo Lee
Journal: J Bacteriol Date: 2008-12-12 Impact factor: 3.490

Avirulent anthrax vaccine.

1. Bacillus anthracis sortase A (SrtA) anchors LPXTG motif-containing surface proteins to the cell wall envelope.

2. Antibacterial photosensitization through activation of coproporphyrinogen oxidase.

3. Surface protein IsdC and Sortase B are required for heme-iron scavenging of Bacillus anthracis.

Review 4. The Bacillus cereus Group: Bacillus Species with Pathogenic Potential.

Review 5. New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.

6. The Bacillus anthracis protein MprF is required for synthesis of lysylphosphatidylglycerols and for resistance to cationic antimicrobial peptides.

7. BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis.

8. Functional comparison of the two Bacillus anthracis glutamate racemases.

9. Vaccine protection against Bacillus cereus-mediated respiratory anthrax-like disease in mice.

10. Bacillus anthracis tagO Is Required for Vegetative Growth and Secondary Cell Wall Polysaccharide Synthesis.